NexThera Co., Ltd.
PrivateLast Round
Strategic
Mar 26, 2024
Total Funding Raised
$12.5M
Company Overview
NexThera Co., Ltd. is a biotechnology company that develops recombinant protein-based platform technologies for novel therapeutics and drug delivery systems, focusing on treatments for wet age-related macular degeneration and thrombocytopenia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NexThera Co., Ltd. Comparables
Compare NexThera Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Olive Bio Therapeutics | 80% | |
| AptaBio Therapeutics Inc | 78% | |
| Inspharmtech, Inc. | 73% |
NexThera Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 26, 2024 | ||||
| Series A Extension | Dec 11, 2023 | ||||
| Series A | Jan 8, 2022 |
NexThera Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Series A |
| KB Investment | Series A Extension |
| Ministry of Science and ICT of South Korea | Grant |
| Woori Venture Partners Co., Ltd. | Series A Extension |
| KB Securities | Series A, Series A Extension |
| Daol Investment | Series A |
| BNK Venture Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2024
$2.23M raised from BMI Korea and EyeGene Inc.
- Dec 11, 2023
$4.2M round led by Fast Ventures and Solidus Investment.
NexThera Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NexThera Co., Ltd.'s valuation, stock price, and market status.
Is NexThera Co., Ltd. a public or private company?
NexThera Co., Ltd. is a private company.
What is the current stock price of NexThera Co., Ltd.?
NexThera Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is NexThera Co., Ltd. worth (valuation)?
Valuation information for NexThera Co., Ltd. is not publicly available.
Can I buy NexThera Co., Ltd. stock?
NexThera Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NexThera Co., Ltd.'s last funding round?
NexThera Co., Ltd.'s most recent funding round was Strategic on March 26, 2024.
Who are the main investors in NexThera Co., Ltd.?
Key investors in NexThera Co., Ltd. include Solidus Investment, Fast Ventures.
Will NexThera Co., Ltd. IPO soon?
No public IPO plans have been announced for NexThera Co., Ltd..
How can I track NexThera Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NexThera Co., Ltd.'s secondary market activity and sign up for updates.